Please provide your email address to receive an email when new articles are posted on . Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to ...
MeiraGTx receives FDA Rare Pediatric Disease Designation for AAV8-RK-RetGC to treat Leber congenital amaurosis due to GUCY2D mutations. MeiraGTx Holdings Plc announced that the FDA has granted its ...
Two people with a rare inherited eye disorder have had their night vision restored by an experimental gene therapy, researchers say. These two individuals are part of an ongoing clinical trial testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback